Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Uterine Cervical Neoplasms × capivasertib × Clear all

Sponsor

Conditions

Triple Negative Breast Neoplasms 2 Recurrence 1 Neoplasms 1 Lymphoma, Mantle-Cell 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, B-Cell 1 Breast Neoplasms 1 Advanced Solid Malignancy, 1

Interventions

Cisplatin 28 human papillomavirus vaccine, L1 type 16, 18 16 Brachytherapy 13 Bevacizumab 11 Paclitaxel 10 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 10 Platinum 9 1,2-diaminocyclohexaneplatinum II citrate 9 Topotecan 8 Radiation 8 Papillomavirus Vaccines 8 Radiotherapy, Intensity-Modulated 7 pembrolizumab 6 Cyclophosphamide 6 tisotumab vedotin 5 fludarabine phosphate 5 fludarabine 5 aldesleukin 5 Radiotherapy 5 Magnetic Resonance Spectroscopy 5 Gemcitabine 5 Fluorodeoxyglucose F18 5 Carboplatin 5 atezolizumab 4 Vaccines, Synthetic 4 Taxes 4 Nivolumab 4 Colposcopy 4 Tobacco Use Cessation Devices 3 Surveys and Questionnaires 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡